Helmut-Heinrich Buschmann

Title: Helmut-Heinrich Buschmann: Innovator in Neuropeptide Research

Introduction

Helmut-Heinrich Buschmann, based in Aachen, Germany, is an accomplished inventor recognized for his contributions to medical research, particularly in the field of neuropeptide Y5 (NPY5) ligands. With a single patent to his name, Buschmann's work addresses critical health issues such as obesity and related disorders.

Latest Patents

Buschmann's notable patent is for "2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide Y5 (NPY5) ligands for the treatment of obesity." This innovative patent aims to provide novel compounds that may be used as active substances in medicaments. Specifically, his invention focuses on the regulation of neuropeptide Y receptors, particularly the NPY5 receptor, which is pivotal in managing food intake and treating various disorders related to food ingestion and beyond.

Career Highlights

While working at Laboratorios Del Dr. Esteve S.A., Buschmann has contributed significantly to the understanding of neuropeptides in therapeutic applications. His research encompasses not only obesity but also broader health challenges including anxiety, depression, cognitive disorders, cardiovascular diseases, and more.

Collaborations

Buschmann has collaborated with notable coworkers Antoni Jover Torrens and Josep Mas Prio. Together, they have advanced research within their field, combining their expertise to foster innovation and development of novel therapeutic approaches.

Conclusion

Helmut-Heinrich Buschmann exemplifies the impact of dedicated research on health-related issues. His patent highlights the potential of neuropeptide Y5 ligands in treating obesity and related conditions, reflecting a commitment to improving the well-being of individuals. As medical research continues to evolve, inventors like Buschmann play a crucial role in shaping future treatments.